3d Impact supported over 350 Research and Innovation Projects


Roy Pennings in panel discussion with EC Director-General for Research Robert-Jan Smits during the February 2016 ScienceBusiness conference on the mid-term evaluation of H2020.

3d Impact has over 18 years of experience in innovation management and fundraising. Over 350 EU research & innovation projects were supported through brainstorming sessions, concept-development, consortium-creation, proposal writing, proposal reviews and project implementation support.

Over the past years, a large number of academic and industrial organisations (corporates as well as SMEs) have used this expertise to make decisions on growth strategies in the context of European innovation policy and funding support. Please click on the LinkedIn Logo to see a selection of the EU research and innovation projects that Roy was actively involved in during their development, writing and/or management phases.

The projects - funded through different EU programmes - range from fundamental science in physics, chemistry, earth sciences, medicine and linguistics to innovations in sustainable energy (wind, solar, thermal), transportation and EU cultural identity. EU funding programmes in which proposal writing or project management support was provided to support clients include: H2020 (incl. ERC and SME-Instrument), FP7, FP6, COST, LIFE/LIFE+, NER300, EEPR, CEF, TEN-e, TEN-t, Interreg, ESF, LifeLong Learning Programme (Leonardo), CIP, EIB Project Loans, HEALTH, MEDIA, TWINNING, KIC (via EIT), EUROSTARS.


Following a recent project coordinatorship of the H2020 ESS BrightnESS project, Roy Pennings recently took up (on in-house consultancy basis) the role of overall operational project coordinator of the H2020-ECSEL SECREDAS project. The project consortium (overall budget of over €51 Million and 69 partner organisations) is developing next generation safety, security and privacy reference architectures and common elements  for the automotive sector and for medical, railway and aerospace applications. The envisioned technical results will help OEMs, Tier1 and Tier2 companies to further develop and enhance the trustworthiness of future European autonomous transportation and medical uses. The project will run until May 2021.